Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2011

01-05-2011 | Correspondence

Gastric Cancer: Two Epidemics?

Author: Pelayo Correa

Published in: Digestive Diseases and Sciences | Issue 5/2011

Login to get access

Excerpt

The recent report by Sonnenberg [1] examines the time trends in gastric cancer and may reflect two epidemics, defined as an unexpected rise in the frequency of a disease. The report calls attention to the “enigma” of the rise in mortality rates from gastric cancer and peptic ulcer in cohorts born after the second half of the eighteenth century. Although the causes of this rise are unknown, it is pertinent to explore the possible link between the secular trends in gastric cancer incidence and the secular trends in the genome of Helicobacter pylori, the most prominent cause of gastric cancer. The bacterium is well known for its propensity to genetic recombination. The more virulent strains are characterized by the presence of a pathogenicity island (PAI), a cluster of about 40 genes containing the cagA gene and genes encoding components of a Type IV secretion system which injects the CagA protein into the cytoplasm of the gastric epithelial cells. The island is acquired after recombination with other bacteria, leading to the importation of an insertion sequence IS605 into the genome of H. pylori [2]. That insertion may contain several DNA sequences and result in strains of several degrees of virulence. The complete PAI insertion characterizes the more virulent strains (cagA positive), linked to peptic ulcer and gastric cancer. Another indication of the impact of secular changes in the H. pylori genome has been reported. It is assumed that the original Asian settlers of the Americas, thousands of years ago, brought with them HpAsian strains, of recognized low virulence. But today’s Amerindians harbor HpEurope, more virulent strains containing PAIs and associated with higher gastric cancer risk [3]. It would appear that the rise in gastric cancer rates observed for cohorts born after the mid-eighteenth century may be linked to environmental as well as secular trends in the evolution of the H. pylori genome. …
Literature
2.
go back to reference Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease associated virulence factors. Proc Natl Acad Sci USA. 1996;93:14648–14653.PubMedCrossRef Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease associated virulence factors. Proc Natl Acad Sci USA. 1996;93:14648–14653.PubMedCrossRef
4.
go back to reference Aragones N, Pollan M, Lopez-Abente G, et al. Time trends and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain. J Epidemiol Community Health. 1997;51:412–417.PubMedCrossRef Aragones N, Pollan M, Lopez-Abente G, et al. Time trends and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain. J Epidemiol Community Health. 1997;51:412–417.PubMedCrossRef
5.
go back to reference Anderson W, Camargo MC, Fraumeni JP, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1–6.CrossRef Anderson W, Camargo MC, Fraumeni JP, et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1–6.CrossRef
Metadata
Title
Gastric Cancer: Two Epidemics?
Author
Pelayo Correa
Publication date
01-05-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1642-x

Other articles of this Issue 5/2011

Digestive Diseases and Sciences 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.